​

1. ​la Cour EE, Malange VNE, Mohaissen T, Christiansen M, Brok JS, Gade C, Lausten-Thomsen U, Hedley PL. Causes of neonatal mortality in the European Economic Area and Switzerland: a WHO-based analysis and systematic review. Eur J Pediatr. 2025 Sep 22;184(10):628. doi: 10.1007/s00431-025-06467-0. PMID: 40976833; PMCID: PMC12450820.​

   ---

   ​
   
2. Gotfredsen DR, Heerfordt IM, Storm Baden C, Horwitz H, Gade C, Andersen JT. Prescription drug use in breastfeeding mothers and infant exposure: A register-based cohort study. Br J Clin Pharmacol. 2025 Oct;91(10):2979-2987. doi: 10.1002/bcp.70139. Epub 2025 Jun 13. PMID: 40511545; PMCID: PMC12464615.​

   ---

   ​
   
3. Lausten-Thomsen U, Olsen RH, Christiansen M, Hedley PL, Heerfordt IM, Andersen JT, Gade C. Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study. Pharmaceuticals (Basel). 2025 Jun 18;18(6):917. doi: 10.3390/ph18060917. PMID: 40573312; PMCID: PMC12195779.​

   ---

   ​
   
4.  Heerfordt, I. M., Andersen, J. T., Gade, C., Gotfredsen, D. R., Horwitz, H., Lausten-Thomsen, U., & Olsen, R. H. (2025). Infant adverse reactions to drugs in human milk reported to the Danish Medicines Agency from 2013 to 2023. Adverse Drug Reaction Bulletin, 353(1), 1371-1374.​​

   ---

   ​
   
5. Heerfordt IM, Gotfredsen DR, Horwitz H, Stark AK, Andersen JT, Gade C, Lausten-Thomsen U, Olsen RH. EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding. Br J Clin Pharmacol. 2025 Apr 6. doi: 10.1002/bcp.70063. Epub ahead of print. PMID: 40190021.​

   ---

   
   ​
   

​​1. Holst, S. S., Møller, ​C. H., Vermehren, C., Trolle, S., Hansen, B., Kirkedal, A-B. K., Christensen, H. R., Jacobsen, T., Mathiasen, R., Andersen, J. Þ. T., & Gade, C. (2024). Establishment of a Children's Drugs and Therapeutics Committee to ensure evidence-based and cost-effective medical treatment for children. British Journal of Clinical Pharmacology, 90(2), 378-387. https://doi.org/10.1111/bcp.15944​

​

3. Esmann CF, Gade C. Adipositas hos børn og unge. Månedsskrift for almen praksis marts 2024. Https://www.maanedsskriftet.dk/mpl/2024/399/13706/ 

​

4. Anne Ostenfeld, Sofie Lyngholm, Sarah Emilie Christensen, Tonny Studsgaard Petersen, Jon Trærup Andersen, Hanne Brix Westergaard, Lars Henning Pedersen, Ellen Christine Leth Løkkegaard​ https://onlinelibrary.wiley.com/doi/full/10.1111/acps.13749​

​​​

6. Mia Finserås Bretun, Ditte Resendal Gotfredsen, Charlotte Vermehren, Jón Þór Trærup Andersen, Christina Gade, Ulrik Lausten-Thomsen, Aase M. Raddum. The Global Extent of Polypharmacy in Neonatal Intensive Care. PROSPERO 2​​024 Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD42024626509​​

​

1.       Ankarfeldt MZ, Petersen J, Andersen JT, Fernandes MFS, Li H, Motsko SP, Fast T, Jimenez-Solem E. 2023. Duloxetine Exposure During Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study. Drugs - real world outcomes. 10(1):69-81. https://doi.org/10.1007/ s40801-022-00334-

​

2.       Baden CS, Andersen JT, Christensen MB, Gade C. 2023. Safety of glucagon-like peptide-1 receptor agonists for weight management in adults, adolescents, and children with obesity: A scoping review. Adverse Drug Reaction Bulletin. 339(1):1315-1318. https://doi.org/10.1097/ FAD.0000000000000067

​

3.       Daoud A, Gade C, Bøgevig S, Christensen MB, Dalhoff KP, Petersen TS. 2023. Paracetamol medication errors areassociated with a high risk ofhepatotoxicity in children aged 0–6years: a retrospective cohort study. Abstract fra European Association of Poisons Centres and Clinical Toxicologists, Mallorca, Spanien. https://doi.org/10.1080/1556365 0.2023.2192024​

4.       Edemann Callesen H, Tarp S, Ussing A, Andersen HK, Krogh C, Virring A, Gade C, Tornbjerg Pedersen, I, Nielsen JD, Baandrup L, et al. 2023. Søvnproblemer hos børn og unge. Rationel Farmakoterapi. 2023(1):1-4, 6-7

​

5.       Edemann-Callesen H, Andersen HK, Ussing A, Virring A, Jennum P, Debes NM, Laursen T, Baandrup L, Gade C, Dettmann J, et al. 2023. Use of melatonin for children and adolescents with chronic insomnia attributable to disorders beyond indication: a systematic review, meta-analysis and clinical recommendation. EClinicalMedicine. 61:102049. https://doi.org/10.1016/j. eclinm.2023.102049

​

6.       Edemann-Callesen H, Andersen HK, Ussing A, Virring A, Jennum P, Debes NM, Laursen T, Baandrup L, Gade C, Dettmann J, et al. 2023. Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation. EClinicalMedicine. 61:102048. https://doi.org/10.1016/j. eclinm.2023.102048​

7.       Eliasen A. 2023. Response to comment on "Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy". Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners. 29(3):520. https://doi. org/10.1177/10781552231152783

​

8.       Eliasen A, Kornholt J, Mathiasen R, Brok J, Rechnitzer C, Schmiegelow K, Dalhoff K. 2023. Risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy. Journal of oncology pharmacy practice: official publication of the International Society of Oncology Pharmacy Practitioners. 29(6):1361-1368. https://doi. org/10.1177/10781552221122026​

9.       Gade C, Trolle S, Mørk M-L, Lewis A, Andersen PF, Jacobsen T, Andersen J, Lausten-Thomsen U. 2023. Massive presence of off-label medicines in Danish neonatal departments: A nationwide survey using national hospital purchase data. Pharmacology Research & Perspectives. 11(1):e01037. https://doi. org/10.1002/prp2.1037​

10.   Händel MN, Andersen HK, Ussing A, Virring A, Jennum P, Debes NM, Laursen T, Baandrup L, Gade C, Dettmann J, et al. 2023. The short-term and long-term adverse effects of melatonin treatment in children and adolescents: a systematic review and GRADE assessment. EClinicalMedicine. 61:102083. https://doi.org/10.1016/j. eclinm.2023.102083

​

11.   Haslund-Krog S, Barry JM, Birnbaum AK, Dalhoff K, Brink Henriksen T, Sherwin CMT, Avachat C, Poulsen S, Christensen U, Remmel RP, et al. 2023. Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort study. British Journal of Clinical Pharmacology. 89(11):3421-3431. https://doi.org/10.1111/ bcp.15834​

12.   Holst SS, Møller CH, Vermehren C, Trolle S, Hansen B, Kirkedal A-BK, Christensen HR, Jacobsen T, Mathiasen R, Andersen JÞT, et al. 2023. Establishment of a Children's Drugs and Therapeutics Committee to ensure evidence-based and cost-effective medical treatment for children. British Journal of Clinical Pharmacology. https://doi.org/10.1111/ bcp.15944

​

13.   Lægteskov TR, Holm KG, Petersen M, Lysdal RK, Hjelvang BR, Brødsgaard A. 2023. Father Groups in the Neonatal Intensive Care Unit: A Supportive Intervention. Advances in neonatal care: official journal of the National Association of Neonatal Nurses. https://doi. org/10.1097/ANC.0000000000001092​

14.   Thøgersen PL, Gotfredsen DR, Gade C, Horwitz H, Andersen JT. 2023. Safety of pharmacologically induced lactaction. Adverse Drug Reaction Bulletin. 341(1):1323-1326. https://doi.org/10.1097/ FAD.0000000000000069

​

15.   Windfeld-Mathiasen J, Horwitz H, Andersen JB, Framke E, Gade C, Andersen JT, Magyari M. 2023. Interferon-beta exposure in-utero and the risk of infections in early childhood. Multiple Sclerosis and Related Disorders. 77: Article 104867. https://doi.org/10.1016/j. msard.2023.104867​​​​​

​​